Newsroom

Sorted by: Latest

-

Samson Rock Capital LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....
-

KBRA Releases 2026 European Structured Finance Symposium Recap

LONDON--(BUSINESS WIRE)--KBRA releases its recap of the European Structured Finance Symposium, held in London on 3 November 2026. The symposium featured a fireside chat with KBRA European Macro Strategist Gordon Kerr, exploring the expanding role of private credit and asset-backed finance in Europe. Discussions considered the evolving relationship between banks and private capital as resilient but modest economic growth, regulatory developments, and geopolitical uncertainty shape the outlook fo...
-

Marathon Asset Management Ltd UK Regulatory Announcement: Form 8.3 Irish Continental Group Plc

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Marathon Asset Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust...
-

Phillips Medisize Acquires Chippenham Facility to Expand Global Inhalation Center of Excellence

CHIPPENHAM, England & HUDSON, Wis.--(BUSINESS WIRE)--Phillips Medisize, a Molex company and a leader in the design, development, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, today announced an investment to acquire the complete footprint of its Chippenham site. Together with its Cambridge location, the newly acquired facility strengthens the company’s Global Inhalation Center of Excellence (COE) and provides additional capacity to suppo...
-

SES Delivers Solid 9 Months & Q3 2026 Results and Reiterates Full-Year Outlook

LUXEMBOURG--(BUSINESS WIRE)--SES S.A. announces financial results for the nine and three months ended September 30, 2026. YTD 2026 Performance (€ million) YTD 2026 as reported (1) YTD 2025 as reported (1)(5) ∆ At constant FX (2) YTD 2025 like-for-like(3) ∆ At constant FX (2) Average €/$ FX rate 1.16   1.11       1.11     Revenue 2,472   1,743   +45.5%   2,628   -2.0% Adjusted EBITDA (4) 1,138   838   +40.0%   1,170   +1.4% 1) ‘Reported basis’ with Intelsat fully consolidated from July 17, 2025...
-

Marathon Asset Management Ltd UK Regulatory Announcement: Form 8.3 easyJet Plc

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Marathon Asset Management Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must...
-

I’m green™ bio-based Polyethylene, Produced From Sugarcane-Derived Renewable Feedstock, Incorporated Into Mondi’s Flexible Pouch

ROTTERDAM, Netherlands--(BUSINESS WIRE)--At Interpack 2026, I’m green™ bio-based and Mondi presented a forward-thinking approach to flexible packaging, combining renewable material innovation with process simplicity to reduce environmental impact without compromising functionality. Renewable materials meet flexible packaging At the heart of the solution is Mondi’s re/cycle StripPouch, made with at least 98% I’m green™ bio-based polyethylene derived from renewable sugarcane, offering an alternat...
-

Amphista Therapeutics to Present AMX-883 Data at American Society of Hematology (ASH) Annual Meeting

CAMBRIDGE, England--(BUSINESS WIRE)--Amphista Therapeutics Limited (‘Amphista’ or ‘the Company’), a clinical-stage biopharmaceutical company focused on the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced new data on its lead therapeutic candidate, AMX-883, has been accepted for oral presentation at American Society of Hematology (ASH) Annual Meeting in New Orleans, December 12–15, 2026. The full abstract is available online: www.hema...
-

Mobix Labs Lands Tier-One Aerospace Orders for Fighter Jets and Wide-Body Aircraft Components

IRVINE, Calif.--(BUSINESS WIRE)--Mobix Labs, Inc. (Nasdaq: MOBX), a U.S.-based provider of advanced, mission-critical electronic components for aerospace and defense applications, today announced a new six-figure production order from a tier-one global aerospace and defense supplier for specialized engine-system components supporting multiple U.S. fighter jet platforms and wide-body commercial aircraft. The new order marks another expansion of Mobix Labs' aerospace business, extending the Compa...
-

European Enterprises Face Growing Pressure to Turn AI Investment into Business Value, ISG Says

PARIS--(BUSINESS WIRE)--The ISG AI Impact Summit will explore operating models and data and governance frameworks to scale AI, November 9–10 at the Pullman Paris Tour Eiffel....